Thermo Fisher, NanoPin partner on infectious disease tech

By The Science Advisory Board staff writers

February 13, 2020 -- Thermo Fisher Scientific will partner with infectious diseases diagnostic company NanoPin Technologies to develop workflows for liquid chromatography-mass spectrometry (LC-MS).

The partnership will utilize Thermo Fisher's LC-MS technology and NanoPin's diagnostic platform to identify disease-related antigens from patient blood samples. The goal is that the companies' combined technologies will lead to the development of clinical assays for infectious diseases, ultimately reducing time to results.

Thermo Scientific launches reagent dispensers
Thermo Scientific has launched a new family of high-precision digital reagent dispensers that are designed to facilitate the miniaturization of assays...
Thermo Fisher posts 5% higher sales in Q4
Lab and scientific instruments manufacturer Thermo Fisher Scientific posted revenues for the fourth quarter of 2019 that were up 4.9%, while net income...
Thermo Fisher launches new compressor-free plate sealer
Thermo Fisher Scientific has released its ALPS 5000 plate sealer and is showing the product at the 2020 Society for Laboratory Automation and Screening...

Copyright © 2020 scienceboard.net


Conferences
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter